Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Condensates as a Culprit in RAS Activation and Inhibitor Resistance. | Cancer Res | 2025 | 40053457 | PubTator, text mining | PubMed |
| Integrative machine learning model of RNA modifications predict prognosis and treatment response in patients with breast cancer. | Cancer Cell Int | 2025 | 39948551 | PubTator, text mining | PubMed |
| Insight on the heterocyte patterning and the proheterocyte division in the toxic cyanobacterium Kaarinaea lacus gen. nov., sp. nov., and its genomic potential for natural products. | Harmful Algae | 2025 | 39947850 | PubTator, text mining | PubMed |
| Plasma membrane-associated ARAF condensates fuel RAS-related cancer drug resistance. | Nat Chem Biol | 2025 | 39870764 | PubTator, text mining | PubMed |
| Structural Insights Into the Impact of the Glycine-Rich Loop Mutation in Noonan Syndrome on the ATP Binding Pocket of CRAF Kinase. | Proteins | 2025 | 39739408 | PubTator, text mining | PubMed |
| CARM1 accelerates the growth of liver cancer cells by enhancing ARAF. | Genes Dis | 2025 | 39415943 | PubTator, text mining | PubMed |
| MEK inhibitors and DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, prevent the migration and invasion of KRAS-mutant cancer cells. | Cytoskeleton (Hoboken) | 2025 | 38872577 | PubTator, text mining | PubMed |
| Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell Histiocytosis. | Arch Pathol Lab Med | 2025 | 38749502 | PubTator, text mining | PubMed |
| [Correlation of BRAF V600E Mutation with Clinical Features and Prognosis of Langerhans Cell Histiocytosis in Cildren]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39743286 | PubTator, text mining | PubMed |
| Beyond BRAFV600E: Investigating the Clinical and Genetic Spectrum of Langerhans Cell Histiocytosis in Children. | Cancer Med | 2024 | 39711503 | PubTator, text mining | PubMed |
| ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. | Cancers (Basel) | 2024 | 39456595 | PubTator, text mining | PubMed |
| Comparison of structure and the synergistic anti-hepatocellular carcinoma effect of three polysaccharides from vinegar-baked Radix Bupleuri. | Int J Biol Macromol | 2024 | 39442850 | PubTator, text mining | PubMed |
| The RAF cysteine-rich domain: Structure, function, and role in disease. | Adv Cancer Res | 2024 | 39306370 | PubTator, text mining | PubMed |
| Genomic landscape of early-stage prostate adenocarcinoma in Mexican patients: an exploratory study. | Discov Oncol | 2024 | 39196408 | PubTator, text mining | PubMed |
| Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases. | Transl Oncol | 2024 | 39154426 | PubTator, text mining | PubMed |
| Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis. | Ophthalmol Sci | 2024 | 39071917 | PubTator, text mining | PubMed |
| Genomic analysis of bladder urothelial carcinoma with osteoclast‑like giant cells: A case report. | Mol Clin Oncol | 2024 | 38978973 | PubTator, text mining | PubMed |
| Profiling Complex RAS-Effector Interactions Using NMR Spectroscopy. | Methods Mol Biol | 2024 | 38570461 | PubTator, text mining | PubMed |
| Mitochondrial Raf1 Regulates Glutamine Catabolism. | bioRxiv | 2024 | 38496616 | PubTator, text mining | PubMed |
| Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex. | Life Sci Alliance | 2024 | 38453365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=3